Citizens Reiterates Market Perform on enGene Therapeuticsto Market Perform

Benzinga · 1d ago
Citizens analyst Silvan Turkcan reiterates enGene Therapeutics (NASDAQ:ENGN) from Market Perform to Market Perform.